Log in to save to my catalogue

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9892211

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Persistence or recurrence of large B-cell lymphoma after CD19-CAR-T is common, yet data guiding management are limited. We describe outcomes and features following CAR-T treatment failure. Of 305 adults who received CD19-CAR-T, 182 experienced disease recurrence or progression (1-year cumulative incidence 63% [95%CI: 57–69]). Of 52 post-CAR-T biops...

Alternative Titles

Full title

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9892211

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9892211

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-022-01739-2

How to access this item